Ontology highlight
ABSTRACT:
SUBMITTER: White H
PROVIDER: S-EPMC4320294 | biostudies-literature | 2015 Feb
REPOSITORIES: biostudies-literature
White H H Deprez L L Corbisier P P Hall V V Lin F F Mazoua S S Trapmann S S Aggerholm A A Andrikovics H H Akiki S S Barbany G G Boeckx N N Bench A A Catherwood M M Cayuela J-M JM Chudleigh S S Clench T T Colomer D D Daraio F F Dulucq S S Farrugia J J Fletcher L L Foroni L L Ganderton R R Gerrard G G Gineikienė E E Hayette S S El Housni H H Izzo B B Jansson M M Johnels P P Jurcek T T Kairisto V V Kizilors A A Kim D-W DW Lange T T Lion T T Polakova K M KM Martinelli G G McCarron S S Merle P A PA Milner B B Mitterbauer-Hohendanner G G Nagar M M Nickless G G Nomdedéu J J Nymoen D A DA Leibundgut E O EO Ozbek U U Pajič T T Pfeifer H H Preudhomme C C Raudsepp K K Romeo G G Sacha T T Talmaci R R Touloumenidou T T Van der Velden V H J VH Waits P P Wang L L Wilkinson E E Wilson G G Wren D D Zadro R R Ziermann J J Zoi K K Müller M C MC Hochhaus A A Schimmel H H Cross N C P NC Emons H H
Leukemia 20140718 2
Serial quantification of BCR-ABL1 mRNA is an important therapeutic indicator in chronic myeloid leukaemia, but there is a substantial variation in results reported by different laboratories. To improve comparability, an internationally accepted plasmid certified reference material (CRM) was developed according to ISO Guide 34:2009. Fragments of BCR-ABL1 (e14a2 mRNA fusion), BCR and GUSB transcripts were amplified and cloned into pUC18 to yield plasmid pIRMM0099. Six different linearised plasmid ...[more]